| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/09/2005 | WO2005051289A2 Homogeneous preparations of chimeric proteins |
| 06/09/2005 | WO2005030136A3 Tumor vaccine |
| 06/09/2005 | WO2005028630A3 Engineered zinc finger proteins for regulation of gene expression |
| 06/09/2005 | WO2005021592A3 Enhancing the circulating half-life of interleukin-2 proteins |
| 06/09/2005 | WO2004104170A3 Tools for detecting moraxella catarrhalis. |
| 06/09/2005 | WO2004087730A3 Method for producing diverse libraries of encoded polymers |
| 06/09/2005 | WO2004080403A3 Influenza virus vaccine |
| 06/09/2005 | WO2004035743A8 Site specific incorporation of keto amino acids into proteins |
| 06/09/2005 | WO2004025264A3 Rapidly degraded reporter fusion proteins |
| 06/09/2005 | US20050125846 Expression vector comprising nucleotide sequences coding transmembrant transport protein for use in diagnosis, treatment and prevention of thyroid disorders |
| 06/09/2005 | US20050124796 Mouse cytokine receptor |
| 06/09/2005 | US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor |
| 06/09/2005 | US20050124790 Protein fusion comprising sequences capable of being cleaved by ubiquitin cleavage enzyme; isolating heterologous expressed, recombinant polypeptide from mixture |
| 06/09/2005 | US20050124789 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/09/2005 | US20050124570 Using carnitine for producing genetic engineered proteins |
| 06/09/2005 | US20050124066 Generating and identifying shuffled plasmid variants comprising linearizing circular plasmid, introduce plasmid into host cell, cultivating cell, screening for recombined gene sequences and polypeptides |
| 06/09/2005 | US20050124064 Antimicrobial polypeptides from pseudoplectania nigrella |
| 06/09/2005 | US20050124054 Novel proteins and methods for producing the proteins |
| 06/09/2005 | US20050124045 Comprising a peptide linker, and a human IgG Fc variant with amino acid mutations; encoded by DNA from a transfected cell line; culture purification; improved pharmacokinetics, extended serum half-life, side effects reduction; treating chronic anemia due to renal diseases |
| 06/09/2005 | US20050124044 Interleukin-21 analogs |
| 06/09/2005 | US20050124039 Mixing cationic lipid with a polynucleotide, coding for antigenic determinant, thereby forming a cationic lipid-polynucleotide complex; administering complex to animal for eliciting an immune response |
| 06/09/2005 | US20050124035 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and methd for producing alpha-L-aspartyl-l-phenylalanine-alpha-methyl esther |
| 06/09/2005 | US20050124004 Histamine receptor h3 polynucleotides |
| 06/09/2005 | US20050123997 Modified fVIII having reduced immunogenicity through mutagenesis of A2 and C2 epitopes |
| 06/09/2005 | US20050123991 Nucleotide sequences coding hydrolase capable of resolving enantiomeric mixtures of alcohol or ester substrates; for use in regio-and stereoselective biotransformations |
| 06/09/2005 | US20050123961 Human G-protein coupled receptors |
| 06/09/2005 | US20050123925 Compositions and methods for the diagnosis and treatment of tumor |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123910 Nucleotide sequences coding prolyl oligopeptidase (DPP10) for use in identifying modulator which prevent and treat allergies, asthma, skin and inflammatory diseases |
| 06/09/2005 | US20050123646 Cheese flavour ingredient and method of its production |
| 06/09/2005 | US20050123569 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
| 06/09/2005 | US20050123568 Chromatographic purification steps using unbuffered aqueous bases as eluent and subsequent neutralization; low side effect for specific immunotherapy of this pollen allergy; reduced immunoglobulin E binding with simultaneous retention of therapeutically relevant T-cell stimulation |
| 06/09/2005 | US20050123558 Modifeid polypeptide |
| 06/09/2005 | US20050123551 Nucleic acids encoding polypeptides present in normal and neoplastic endometrial cells for use in diagnosis and treatment of endometrial cancer, identifying endometrial tissue; vectors, host cells; vaccines against endometrial cancer |
| 06/09/2005 | US20050123549 E.g. an antibody that binds the CA6 glycotope conjugated to a cytotoxic agent such as a maytansine; kit with instructions for treating cancer and tumors |
| 06/09/2005 | US20050123546 Polynucleotides; engineered Type II anti-CD20 antibodies with altered glycosylation; vectors and host cells; treatment of B cell lymphomas |
| 06/09/2005 | US20050123545 Diagnosis and treatment of malignant neoplasms |
| 06/09/2005 | US20050123541 Anti-TNF antibodies, compositions, methods and uses |
| 06/09/2005 | US20050123534 Humanised antibodies |
| 06/09/2005 | US20050123533 Prodrugs activated by targeted catalytic proteins |
| 06/09/2005 | US20050123532 Method of activating protein |
| 06/09/2005 | US20050123519 nucleotide sequences, expression vectors and host cells, used for increasing the toxicity of insecticidal proteins to mosquitoes |
| 06/09/2005 | US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 06/09/2005 | US20050123508 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders |
| 06/09/2005 | US20050123456 Device and method for processing biological or chemical substances or substance mixtures thereof |
| 06/09/2005 | DE4142157B4 Opioid-Peptide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzung Opioid peptides, process for their preparation and pharmaceutical composition containing the |
| 06/09/2005 | CA2547456A1 Means and methods for the determination of camp in vitro and in vivo |
| 06/09/2005 | CA2546580A1 Homogeneous preparations of chimeric proteins |
| 06/09/2005 | CA2546343A1 Methods for purifying pertussis toxin and peptides useful therefor |
| 06/09/2005 | CA2546222A1 Methods and reagents for treating, preventing and diagnosing bunyavirus infection |
| 06/09/2005 | CA2545867A1 Anti-il-20 antibodies and binding partners and methods of using in inflammation |
| 06/09/2005 | CA2545610A1 Auxotrophic pseudomonas fluorescens bacteria for recombinant protein expression |
| 06/09/2005 | CA2543566A1 B-cell-targeted toxin for immuno response reduction |
| 06/09/2005 | CA2542546A1 Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation |
| 06/08/2005 | EP1538210A2 Dna-based vaccination of fish by immersion |
| 06/08/2005 | EP1538209A2 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 06/08/2005 | EP1538204A2 Mutated subtilisin genes |
| 06/08/2005 | EP1538201A1 Method for the recombinant production and purification of protein kinases |
| 06/08/2005 | EP1538198A2 Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same |
| 06/08/2005 | EP1537417A2 Method of diagnosing colon and gastric cancers |
| 06/08/2005 | EP1537229A2 Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 06/08/2005 | EP1537228A2 Modulators of angiogenesis |
| 06/08/2005 | EP1537207A2 Recombinant colstridium neurotoxin fragments |
| 06/08/2005 | EP1537205A2 Viral deconstruction through capsid assembly in vitro |
| 06/08/2005 | EP1537138A2 Receptors and membrane-associated proteins |
| 06/08/2005 | EP1537137A2 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 06/08/2005 | EP1536834A2 Design of chemokine analogs for the treatment of human diseases |
| 06/08/2005 | EP1536829A2 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease |
| 06/08/2005 | EP1536828A2 Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 06/08/2005 | EP1497469A4 Assay for evaluation of activity of compounds against hcv using a novel detection system in the hcv replicon |
| 06/08/2005 | EP1399580A4 Secretion of proteins by encapsulated cells |
| 06/08/2005 | EP1097174B1 Lupus anticoagulant antibody to f1 region of prothrombin |
| 06/08/2005 | EP1092017A4 Novel gaba-b receptor |
| 06/08/2005 | EP0997152B1 Antibodies as REMEDIES FOR LYMPHOCYTIC TUMORS (EXCEPT MYELOMA) |
| 06/08/2005 | EP0843722B1 Regulated autocrine growth of mammalian cells |
| 06/08/2005 | EP0794251B1 D-pantolactone hydrolase and gene encoding the same |
| 06/08/2005 | EP0793504B1 Chimeric cytokines and uses thereof |
| 06/08/2005 | CN1625596A Transcriptional factor, transcriptional factor gene, recombinant vector containing transcriptional factor gene, koji-mold transformed by the vector and method of using koji-mold |
| 06/08/2005 | CN1625565A Antibodies to non-functional P2X7 receptor, diagnosis and treatment of cancers and other conditions |
| 06/08/2005 | CN1625562A Chimeric delta-endotoxin protein of CRY1EA and CRY1CA |
| 06/08/2005 | CN1624141A Process for raising expressing content of colyliform virus VPT or VP4 in plant and its product |
| 06/08/2005 | CN1624126A Ret ligand (retl) for stimulating neural and renal growth |
| 06/08/2005 | CN1624123A Method for the recombinant production and purification of protein kinases |
| 06/08/2005 | CN1624115A Cell surface molecule mediating cell adhesion and signal transmission |
| 06/08/2005 | CN1623999A Salt Du's algal nitrate transfer protein and its code sequence |
| 06/08/2005 | CN1623602A Vaccines |
| 06/08/2005 | CN1205227C Intack kinetochore protein compound and its separation method and use |
| 06/08/2005 | CN1205225C Human protein with cancer inhibiting function and its coding sequence |
| 06/08/2005 | CN1205223C Insect poison allergens with reduced LgE reactivity and method for producing the same |
| 06/07/2005 | US6903204 Polynucleotides encoding methionyl tRNA synthetase from Staphylococcus aureus, related products and methods |
| 06/07/2005 | US6903203 Immunoglobulin for use in the diagnosis and therapy of cancer |
| 06/07/2005 | US6903202 DNA encoding proteins that inhibit Hsp70 function |
| 06/07/2005 | US6903200 Transforming or transfecting a host cell with the recombinant vector, culturing such transformed or transfected cell under the conditions sufficient for expression of the human alpha 1 chain collagen protein |
| 06/07/2005 | US6903195 Obtaining a cell sample, lysing or permeabilizing the cells to antibodies, adding antibody to the cell sample, complexing antibody with CDN-1(a protein) and detecting the CDN protein |
| 06/07/2005 | US6903194 Antibody against human parathormone related peptides |
| 06/07/2005 | US6903185 Generating chimeric zinc finger protein; obtain nucleotide sequences coding chimeric protein, transform cells, express nucleotide sequences, recover protein |
| 06/07/2005 | US6903071 Cartilage/bone inducing materials for reparation |
| 06/07/2005 | US6903069 Factor VII glycoforms |
| 06/07/2005 | US6902925 Culture media has the amino acid leucine added for selective production of the beauveriolides; a culture product used to treat arteriosclerosis |
| 06/07/2005 | US6902923 For pharmacogenomic applications; cosmetics; nutriceuticals; fusion proteins |